DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study ; volume:12 ; number:1 ; day:21 ; month:7 ; year:2023 ; pages:1-5 ; date:12.2023
Experimental hematology & oncology ; 12, Heft 1 (21.7.2023), 1-5, 12.2023
- Creator
-
Kim, Stefano
Vendrely, Véronique
Saint, Angélique
André, Thierry
Vaflard, Pauline
Samalin, Emmanuelle
Pernot, Simon
Bouché, Oliver
Zubir, Mustapha
Desrame, Jérôme
Fouchardière, Christelle de la
Smith, Denis
Ghiringhelli, François
Vienot, Angélique
Jacquin, Marion
Klajer, Elodie
Nguyen, Thierry
François, Éric
Taieb, Julien
Le Malicot, Karine
Vernerey, Dewi
Meurisse, Aurélia
Borg, Christophe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-023-00413-2
- URN
-
urn:nbn:de:101:1-2023102516440151441361
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Stefano
- Vendrely, Véronique
- Saint, Angélique
- André, Thierry
- Vaflard, Pauline
- Samalin, Emmanuelle
- Pernot, Simon
- Bouché, Oliver
- Zubir, Mustapha
- Desrame, Jérôme
- Fouchardière, Christelle de la
- Smith, Denis
- Ghiringhelli, François
- Vienot, Angélique
- Jacquin, Marion
- Klajer, Elodie
- Nguyen, Thierry
- François, Éric
- Taieb, Julien
- Le Malicot, Karine
- Vernerey, Dewi
- Meurisse, Aurélia
- Borg, Christophe
- SpringerLink (Online service)
Other Objects (12)
Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis
Glucocorticoids in acute pancreatitis: a propensity score matching analysis
Propensity matching cannot substitute for randomization in albumin studies
Doublet, Heinrich
Doublet - Schulpen
Propensity score interval matching: using bootstrap confidence intervals for accommodating estimation errors of propensity scores
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis
Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
Some practical guidance for the implementation of propensity score matching
Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis
Glucocorticoids in acute pancreatitis: a propensity score matching analysis
Propensity matching cannot substitute for randomization in albumin studies
Doublet, Heinrich
Doublet - Schulpen
Propensity score interval matching: using bootstrap confidence intervals for accommodating estimation errors of propensity scores
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis
Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
Some practical guidance for the implementation of propensity score matching
Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis
Glucocorticoids in acute pancreatitis: a propensity score matching analysis
Propensity matching cannot substitute for randomization in albumin studies
Doublet, Heinrich
Doublet - Schulpen
Propensity score interval matching: using bootstrap confidence intervals for accommodating estimation errors of propensity scores
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis
Head to head comparison of the propensity score and the high-dimensional propensity score matching methods